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Abstract: Acrylamide (AA), used in many fields, from industrial manufacturing to laboratory work, is also formed
during the heating process through the interactions of amino acids. Therefore, AA poses a significant risk for both
human and animal health. This study aimed to elucidate whether N-acetyl-L-cysteine (NAC) treatment could modulate
AA-induced oxidative changes in the brain, lung, liver, kidney, and testes tissues of the rat. Rats were divided into
4 groups, as the control (C), NAC [150 mg/kg intraperitoneally (i.p.)], AA (40 mg/kg i.p.), and NAC + AA groups.
After 10 days, the rats were decapitated and the tissues were excised. Malondialdehyde (MDA) and glutathione (GSH)
levels, and myeloperoxidase activity (MPO) were determined in the tissues, while oxidant-induced tissue fibrosis
was determined using the collagen contents. Serum enzyme activities, cytokine levels, and leukocyte apoptosis were
assayed in the plasma. In the AA group, GSH levels decreased significantly, while the MDA levels, MPO activity, and
collagen content increased in the tissues suggesting oxidative organ damage. In the NAC + AA group, oxidant responses
reversed significantly. Serum enzyme activities, cytokine levels, and leukocyte apoptosis, which increased following
AA administration, decreased with NAC treatment. Therefore, supplementing with NAC can be useful when there is
a risk of AA toxicity, as NAC inhibits neutrophil infiltration, balances the oxidant-antioxidant status, and regulates the
generation of inflammatory mediators to protect tissues.
Key words: Acrylamide, N-acetyl-L-cysteine, oxidative changes, collagen, myeloperoxidase, leukocyte apoptosis

Introduction
Acrylamide (AA), an α, β unsaturated carbonyl
compound with significantly high chemical activity,
is extensively used in many fields, from industrial
manufacturing to laboratory work, (1). AA gained
great public and scientific interest when the World
Health Organization, in 2002, published the
* E-mail: eiemekli@marmara.edu.tr
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concentrations of AA of many foods (2). Specifically,
in foods containing carbohydrates and proteins,
AA is formed through the Maillard reaction during
the heating process by interactions of amino acids,
especially asparagine, with reducing sugars like
glucose (3). Moreover, most dry pet foods contain
cereal grains or potatoes, and they are processed at
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high temperatures providing the conditions for the
Maillard reaction. In fact, the Maillard reaction is
considered desirable in the production of pet food
because it imparts a palatable taste, even though it
reduces the bioavailability of some amino acids,
including taurine and lysine (4).
Oxidative stress and the role of reactive oxygen
species (ROS) in disease and toxicity have been 2 major
issues in biomedical sciences (5,6). Free radicals are
continuously produced in vivo and there are number
of protective antioxidant enzymes (superoxide
dismutase, catalase, glutathione S-transferase,
glutathione peroxidase, and antioxidant glutathione)
for dealing with these toxic substances. The delicate
balance between the production and catabolism of
oxidants is critical for maintenance of the biological
function (7).
N-acetyl-L-cysteine (NAC) is a potent antioxidant
that has been used clinically for decades for the
treatment of many diseases. It derives from the amino
acid L-cysteine and it has been used as a chelator of
heavy metal to protect against oxidative stress and
prevent damage to cells (8). It plays an important role
in the production of glutathione, which provides an
intracellular defense against oxidative stress, and it
participates in the detoxification of many molecules
(9). During the last decade, numerous in vitro and in
vivo studies have suggested that NAC has beneficial
medicinal properties, including the inhibition of
carcinogenesis, tumorigenesis, and mutagenesis, as
well as the inhibition of tumor growth and metastasis
(10,11). Although NAC is an excellent scavenger of
free radicals and chelator of heavy metal, it remains
unclear whether this compound is effective in AAinduced oxidative stress. Hence, the present study
was designed to elucidate whether exposure to
NAC could modulate acrylamide-induced oxidative
changes in the brain, lung, liver, kidney, and testes
tissues of the rat.
Materials and methods
Animals
All of the experimental protocols were approved by
the Marmara University School of Medicine, Animal
Care and Use Committee. Wistar albino rats of
either sex (200-250 g) were housed in a room with a

mean constant temperature of 22 ± 2 °C, a light/dark
photoperiod of 12:12, and ad libitum standard pellet
chow and water.
Experimental groups
The rats were administered Acrylamide (Merck,
800830) (40 mg/kg/day intraperitoneally (i.p.),
dissolved in 0.9% NaCl) followed by either saline
(AA group) or NAC (Sigma, A-7250) (at a dose of
150 mg/kg i.p., dissolved in 0.9% NaCl) (AA + NAC
group) for 10 days. In the control group, saline (0.9%
NaCl) or NAC (150 mg/kg i.p., dissolved in 0.9%
NaCl) was injected for 10 days. Each group consisted
of 6 animals.
Assays
The animals were decapitated on the 10th day, trunk
blood samples were collected, and brain, lung, liver,
kidney, and testis tissues were excised. Blood samples
were used to analyze aspartate aminotransferase
(AST), alanine aminotransferase (ALT), blood urea
nitrogen (BUN), 8-hydroxy-2’-deoxyguanosine (8OHdG), creatinine, lactate dehydrogenase (LDH)
activity, tumor necrosis factor α (TNF-α), and
interleukin (IL)-1β, IL-6, and IL-10. In the brain,
lung, liver, kidney, and testes tissue samples, stored at
–70 °C, malondialdehyde (MDA) as an end product
of lipid peroxidation, glutathione (GSH) as a key
antioxidant, and tissue-associated myeloperoxidase
(MPO) activity as indirect evidence of neutrophil
infiltration were measured. Additional tissue
samples were placed in formaldehyde (10%) for the
determination of collagen content. Serum enzyme
activities, cytokine levels, and leukocyte apoptosis
were assayed in the plasma samples.
Blood urea nitrogen and serum AST, ALT,
and creatinine concentrations and LDH levels
were determined spectrophotometrically using
an automated analyzer (Opera Technican Bayer
Autoanalyzer). Serum levels of TNF-α, IL-1β, IL6, and IL-10 were quantified using enzyme-linked
immunosorbent assay (ELISA) kits specific to the
previously mentioned rat cytokines, according to
the manufacturer’s instructions and guidelines
(Biosource Europe S.A., Nivelles, Belgium). The total
antioxidant capacity in the plasma was measured
using a colorimetric test system (ImAnOx, catalog
no. KC5200, Immunodiagnostic AG, D-64625
439
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Bensheim), according to the manufacturer’s
instructions. The 8-OHdG content in the extracted
DNA solution was determined using the ELISA
method (Highly Sensitive 8-OHdG ELISA kit, Japan
Institute for the Control of Aging, Shizuoka, Japan).
These particular assay kits were selected because of
their high degree of sensitivity, specificity, inter- and
intraassay precision, and small amount of plasma
sample required for conducting the assay.
MDA and GSH assays
Tissue samples were homogenized with ice-cold 150
mM KCl for the determination of MDA and GSH
levels. The MDA levels were assayed for products of
lipid peroxidation by monitoring thiobarbituric acid
reactive substance formation, as described previously
(12). Lipid peroxidation was expressed in terms of
MDA equivalents using an extinction coefficient of
1.56 × 105 M–1 cm–1 and the results were expressed
as nmol MDA/g tissue. GSH measurements were
performed using a modification of the Ellman
procedure (13). GSH levels were calculated using
an extinction coefficient of 1.36 × 104 M–1 cm–1. The
results were expressed in μmol GSH/g tissue.
MPO activity and tissue collagen measurement
MPO, an enzyme released by activated
polymorphonuclear neutrophils, is used as an
indication of tissue neutrophil accumulation. Tissue
MPO activity was measured using a procedure
similar to that documented previously (14). Tissue
samples were homogenized in 50 mM potassium
phosphate buffer (PB, pH 6.0), and centrifuged at
41,400 × g (10 min); pellets were suspended in 50 mM
PB containing 0.5% hexadecyltrimethylammonium
bromide (HETAB). After 3 freeze and thaw cycles
with sonication between the cycles, the samples
were centrifuged at 41,400 × g for 10 min. Aliquots
(0.3 mL) were added to 2.3 mL of reaction mixture
containing 50 mM PB, o-dianisidine, and 20 mM
H2O2 solution. One unit of enzyme activity was
defined as the amount of the MPO present that
caused a change in absorbance measured at 460 nm
for 3 min. MPO activity was expressed as U/g tissue.
Tissue collagen content measurement
Tissue collagen was measured as a free radicalinduced fibrosis marker. Tissue samples were cut
with a razor blade, immediately fixed in 10% formalin
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in 0.1 M phosphate buffer (pH; 7.2) in paraffin, and
sections measuring approximately 15 μm thick were
obtained. Evaluation of the collagen content was
based on the method published by Lopez de Leon
and Rojkind (15), which is based on selective binding
of the dyes Sirius Red and Fast Green FCF to collagen
and noncollagenous components, respectively.
Evaluation apoptosis and cell death
Apoptosis and cell death was evaluated according
to the method of Takei et al. (16). Erythrocytes
from heparinized blood samples of the groups were
discarded using flow cytometry. White blood cells
were washed and resuspended in phosphate buffered
saline-gel. For each apoptosis experiment, 2 tubes were
prepared and 1 × 105 cells/mL were distributed into
the tubes. One of the tubes was induced for apoptosis
using 100 ng/mL of phorbol myristate acetate at 37
°C for 2 h, while other was incubated at the same
temperature without stimulation, as a control. To
demonstrate early apoptosis, the cells were washed
with phosphate buffered saline following stimulation
and were labeled with annexin V, according to the
manufacturer’s instructions (Biovision, Mountain
View, CA, USA).
Statistical analysis
Statistical analysis was carried out using GraphPad
Prism 3.0 (GraphPad Software, San Diego, CA,
USA). Each group consisted of 8 animals. All of the
data were expressed as means ± s.d. Groups of data
were compared with ANOVA followed by Tukey’s
multiple comparison tests. P < 0.05 was considered
as significant.
Results
As an indication of hepatic injury, the ALT and AST
levels were significantly higher in the saline-treated
AA group when compared with those of the control
group (P < 0.001). NAC treatment decreased both the
ALT and AST levels significantly (P < 0.01 and P <
0.001, respectively) compared with the saline-treated
AA group. Serum lactate dehydrogenase (LDH)
activity, as an indicator of generalized tissue damage,
showed a significant increase in the AA group (P <
0.001) and this effect was reversed significantly by
NAC treatment (P < 0.001, Table 1).
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Table 1. Serum ALT, AST, and LDH activities and BUN, Creatinine, and 8-OHdG levels of the 4 groups.
Control

NAC

AA

ALT (U/L)

50.50 ± 5.01

51.67 ± 5.19

114.0 ± 8.90***

74.0 ± 5.46

AST (U/L)

167.3 ± 11.27

171.0 ± 9.85

390.7 ± 33.98***

214.0 ± 9.83

BUN (U/L)

21.0 ± 2.05

22.0 ± 1.75

80.67 ± 11.42***

33.0 ± 3.72

Creatinine (U/L)

0.45 ± 0.08

0.58 ± 0.08

2.08 ± 0.18***

0.80 ± 0.10

2102 ± 194.1

2120 ± 172.0

4293 ± 219.3***

2768 ± 167.0

0.62 ± 0.13

0.66 ± 0.14

7.62 ± 0.84***

3.78 ± 0.28***,

LDH (U/L)
8-OHdG (ng/mL)

AA + NAC
++
+++

+++
+++
+++
+++

Data are mean ± s.d. ***P < 0.001 compared with the control group. ++P < 0.01 and +++P < 0.001 compared with the AA group.

BUN and creatinine levels were significantly
increased in the saline-treated AA group compared
with those of the control group. On the other
hand, NAC treatment significantly decreased these
parameters in the AA group when compared with the
saline-treated AA group (P < 0.001) (Table 1).
In the saline-treated AA group, the plasma TNF-α,
IL-1β, IL-6, and IL-10 levels were significantly
increased compared with the control group (P <
0.001). NAC treatment decreased these parameters
in the AA group when compared with the salinetreated AA group (Figure 1). As an indicator of

In the AA group, GSH levels were decreased
significantly while the MDA levels, MPO activity, and
collagen content increased in the tissues, suggesting
oxidative organ damage. In the NAC + AA group, all
of these oxidant responses were reversed significantly
(Table 2). Moreover, leukocyte apoptosis, which had
increased significantly following AA administration,
decreased with NAC treatment (Figures 2 and 3).

***
Saline-treated
NAC-treated

50
+++
*

25

IL-1β (pg/mL)

TNF-α (pg/mL)

75

oxidative DNA damage, 8-OH dG levels were also
significantly increased in the AA group and this
effect was reversed significantly by NAC treatment
(P < 0.001, Table 1).

0
C

***

+++
*

C

AA

AA

***

125

200

75
+++
50

IL-10 (pg/mL)

100
IL-6 (pg/mL)

700
600
500
400
300
200
100
0

+++
*

100
***

25
0

0
C

AA

C

ACR

Figure 1. Serum TNF-α, IL-β, IL-6, and IL-10 levels of the groups. *P < 0.05 and ***P < 0.001: compared to the salinetreated control group. +++P < 0.001, compared to the saline-treated AA group.
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Table 2. Tissue MDA, GSH, and MPO levels and collagen contents of the 4 groups.
Control

NAC

AA

AA + NAC

27.00 ± 2.39
54.78 ± 3.39
46.27 ± 3.78
27.48 ± 2.24
31.38 ± 3.13

28.58 ± 2.12
54.18 ± 3.39
45.63 ± 3.73
26.83 ± 2.23
31.03 ± 3.16

51.28 ± 2.99
***
87.10 ± 4.18
***
79.12 ± 4.31
***
54.30 ± 2.62
***
57.07 ± 2.87

0.83 ± 0.08
1.93 ± 0.19
2.02 ± 0.08
1.91 ± 0.06
1.20 ± 0.06

0.88 ± 0.06
1.88 ± 0.13
2.10 ± 0.05
1.93 ± 0.07
1.20 ± 0.07

0.46 ± 0.04
***
0.95 ± 0.08
***
0.93 ± 0.07
***
0.97 ± 0.08
***
0.52 ± 0.09

11.75 ± 1.36
24.63 ± 1.71
10.67 ± 0.69
26.57 ± 2.07
8.37 ± 0.82

13.05 ± 1.26
24.98 ± 2.43
10.65 ± 0.69
26.75 ± 2.19
8.92 ± 0.90

28.23 ± 2.19
***
70.50 ± 4.94
***
30.95 ± 2.40
***
57.43 ± 3.29
***
26.28 ± 2.05

9.60 ± 0.65
16.60 ± 0.92
14.75 ± 0.91
13.95 ± 0.94
9.98 ± 1.23

9.75 ± 0.79
17.17 ± 1.01
13.98 ± 1.29
14.58 ± 0.96
9.83 ± 0.95

20.55 ± 1.30
***
34.50 ± 1.27
***
30.95 ± 1.15
***
30.97 ± 2.27
***
20.10 ± 1.35

MDA (nmol/g)
Brain
Lung
Liver
Kidney
Testes

***

+++

34.77 ± 2.39
* ++
68.40 ± 2.32 ,
++
53.73 ± 4.03
+++
33.15 ± 2.38
++
38.22 ± 2.79

GSH (μmol/g)
Brain
Lung
Liver
Kidney
Testes

***

+++

0.89 ± 0.06
++
1.69 ± 0.14
*** +++
1.51 ± 0.09 ,
* +++
1.57 ± 0.08 ,
++
0.93 ± 0.06

MPO (U/g)
Brain
Lung
Liver
Kidney
Testes

***

* ++

18.52 ± 1.73 ,
+++
33.22 ± 3.83
* +++
16.35 ± 0.92 ,
+++
32.62 ± 2.10
* +++
15.37 ± 1.82 ,

Collagen (μg/mg)
Brain
Lung
Liver
Kidney
Testes

***

* +++

13.62 ± 0.98 ,
* +++
21.22 ± 1.22 ,
** +++
20.70 ± 1.28 ,
+++
18.48 ± 1.16
+++
11.97 ± 0.99

Data are mean ± s.d. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the control group. +P < 0.05, ++P < 0.01, and +++P < 0.001
compared with the AA group.

Discussion
In the present study, increases in MDA levels, MPO
activity, and collagen content, as well as the decrease
in GSH levels induced by AA were reversed by NAC
treatment. These findings demonstrate that AAinduced oxidative organ damages in the brain, lung,
liver, kidney, and testes tissues were ameliorated
by NAC treatment. Moreover, impairments in
hepatic and renal functions due to AA were also
improved by NAC treatment, and plasma levels of
the proinflammatory cytokines and oxidative DNA
damage were reduced. These findings suggest that
NAC may be protective against AA-induced oxidative
injury by inhibiting neutrophil infiltration, and
subsequent activation of inflammatory mediators
that induce lipid peroxidation.
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The spontaneous formation of AA during the
cooking of food has led to its description as a
cooking carcinogen (17). In addition to the evidence
of AA mutagenicity (18), genotoxicity (19) and
carcinogenicity (20) have also been reported. AA
therefore poses a potentially significant risk both for
human and animal health. However, the mechanism
by which AA exposure causes cellular dysfunction in
experimental animals and humans is not clear. In the
present study, we provide experimental evidence in
support of the role of oxidative stress in AA toxicity.
Enhancement of lipid peroxidation is a
consequence of depletion of GSH to certain critical
levels. AA is oxidized to glycidamide, a reactive
epoxide, and undergoes conjugation with glutathione.
DNA adducts from glycidamide have been reported
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Figure 2. a) Early apoptosis, b) late apoptosis, and c) cell death in neutrophils in the blood samples of the saline- or NACtreated control and AA groups. Apoptosis and cell death ratios were calculated by dividing the values after
stimulation to the values obtained prior to PMA stimulation. ***P < 0.001 compared to the saline-treated control
group; +++P < 0.001, compared to the saline-treated AA group.
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Figure 3. a) Early apoptosis, b) late apoptosis, and c) cell death in lymphocytes in the blood samples of the saline- or
NAC-treated control and AA groups. Apoptosis and cell death ratios were calculated by dividing the values after
stimulation to the values obtained prior to PMA stimulation. ***P < 0.001 compared to the saline-treated control
group; +++P < 0.001, compared to the saline-treated AA group.
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following the administration of AA (21). AA is
capable of interacting with vital cellular nucelophiles
possessing -SH, -NH2 or -OH. Therefore, it reacts
with GSH in a similar manner and forms glutathione
S-conjugates, which is the initial step in the
biotransformation of electrophiles into mercapturic
acids (22). In the present study, decreased GSH
content and increased lipid peroxidation in tissues
can be explained by the reaction of AA with GSH,
which in turn causes the depletion of GSH and the
enhancement of lipid peroxidation.
Moreover, the depletion of cellular GSH stores
and the change in the redox status of the cell, in
turn, may modulate gene expression directly or via
the transcription factors that are redox-regulated,
and may lead to apoptosis, cell proliferation, or
transformation (23). This may explain significantly
increased leukocyte apoptosis following AA
administration in the present study. Furthermore,
MPO, which is an endogenous lysosomal enzyme that
removes H2O2 and catalyzes the formation of toxic
hypochlorous acid, was increased significantly due to
AA toxicity. Hypochlorous acid interacts with other
small molecules to produce various ROS including
hydroxyl radicals, singlet oxygen, peroxynitrite, and
ozone (24). Previous studies have demonstrated that
MPO derived chlorinated oxidants and hydroxyl
radicals play key roles in inducing oxidative stressmediated apoptosis in myeloid leukemia cells, with
ROS being responsible for triggering apoptosis (25).
NAC is a precursor of GSH and it is used clinically
for a broad spectrum of indications including
mucolysis, detoxification after acetaminophen
poisoning, respiratory distress syndrome, hyperoxiainduced pulmonary damage, HIV infection, cancer,
and heart disease (26). However, it is still not clear if
NAC is an effective antioxidant. In the present study,
the antioxidant balance impaired by AA induction
improved with NAC treatment in the tissues.
Accordingly, increased proinflammatory cytokine
expression can also be associated with the generation
of free radicals, as the oxidative damage marker of
DNA, 8-OHdG levels were significantly increased
in the blood samples of the AA group. Moreover,
MPO activities, which increased due to AA toxicity,
reversed with NAC treatment, as NAC has been
shown to work as a scavenger of the products of the
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MPO system (27). Collagen content, which increased
in the tissues suggesting oxidative organ damage, was
also reversed due to NAC treatment. This finding is
consistent with the findings of Sato et al. (28), who
showed that NAC substantially reduced the hydrogen
peroxide induced elevation of cellular proliferation
and collagen production.
In the literature, an inconsistency exists about the
contribution of ROS to the regulation of apoptosis
(29,30). In the present study, inducers of NF-κB such
as TNF-α and IL-1 were increased significantly due to
AA toxicity, which is associated with increased ROS.
Moreover, leukocyte apoptosis, which increased
significantly following AA administration, decreased
with NAC treatment. Yang et al. (30) demonstrated
that NAC inhibits NF-κB activation by reducing the
inhibitor of kappa B kinase (IKK) activity, and this
may in turn explain decreased leukocyte apoptosis
following NAC treatment.
Most dry pet foods contain cereal grains or
potatoes, and are processed at high temperatures and
high pressure, making AA formation possible. On
the other hand, the content and potential effects of
AA formation in pet foods are unknown. To the best
of our knowledge, this study is the first to investigate
the effects of NAC in AA toxicity on the brain, lung,
liver, kidney, and testes tissues of the rat by evaluating
biochemical, inflammatory, oxidant-antioxidant, and
apoptotic markers. Our results demonstrate that in
AA toxicity NAC protected these tissues by inhibiting
neutrophil infiltration, balancing the oxidantantioxidant status, and regulating the generation of
inflammatory mediators. Therefore, supplementing
with NAC can be useful when there is a risk of AA
toxicity.
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